Improving the health and well-being of patients affected by Alzheimer’s disease
![Improving the health and well-being of patients affected by Alzheimer’s disease](https://d3wo5wojvuv7l.cloudfront.net/t_square_limited_480/images.spreaker.com/original/ba3c00a34204a77fc26d3d9eabcd6e49.jpg)
Regístrate gratis
Escucha este episodio y muchos más. ¡Disfruta de los mejores podcasts en Spreaker!
Descarga y escucha en cualquier lugar
Descarga tus episodios favoritos y disfrútalos, ¡dondequiera que estés! Regístrate o inicia sesión ahora para acceder a la escucha sin conexión.
Descripción
Ram Mukunda and Claudia Grimaldi from IGC Pharma, a clinical stage pharmaceutical company focused on improving the health and well-being of patients affected by Alzheimer’s disease and bringing these therapies...
mostra más- Many people are aware of the symptoms of Alzheimer's including dementia, but many are unaware of that agitation is one of the most common and challenging aspects of care among patients with dementia due to Alzheimer’s disease. Can you explain why?
- How does this condition affect those caring for a patient affected by Alzheimer's?
- How does your investigational drug IGC-AD1 work to help these patients?
- What are the next steps in bringing this drug to market?
- What other therapies is IGC Pharma working on in Alzheimer’s?
Información
Autor | eHealth Radio Network |
Página web | - |
Etiquetas |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company